Kristina Kastreva
Kristina Kastreva has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Benedikt Schoser
Department of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-University, Munich, Germany
2 shared publications Albena Todorova
Genetic Medico-Diagnostic Laboratory 'Genica", Sofia, Bulgaria; Department of Medical Chemistry and Biochemistry, Sofia, Bulgaria
1 shared publication- Andriy Shatillo
Institute of Neurology, Psychiatry and Narcology, Academy of medical science of Ukraine, Kharkiv, Ukraine
1 shared publication Angela Huebner
Children's Hospital Technical University Dresden, Germany
1 shared publication- Ani Taneva
UMHAT "Alexandrovska"; Medical university – Sofia
1 shared publication Anna Kostera-Pruszczyk
Department of Neurology, Medical University of Warsaw, Warszawa, Poland
1 shared publication
Latest Publications
- Open Access
- 30 April 2026
- Published by Bulgarian Society of Neurology in Bulgarian Neurology
- Vol. 27 (1) , 18-21
Синдромът „Едно и половина” на Fisher (Fisher’s “One and a half syndrome”) при миастения гравис - описание на случай
Синдромът „едно и половина” на Fisher е рядка очедвигателна лезия, характеризираща се с хоризонтална погледна пареза в едната посока в съчетание с интернуклеарна офталмопареза в другата посока. Дължи се на унилатерална понтинна лезия, засягаща ипсилатералната парамедианна понтинна ретикуларна формация и/или ипсилатералното ядро на n. abducens и интернуклеарните фибри на ипсилатералния медиален лонгитудинален фасцикул. Описан е при стволови лезии с различна етиология – съдови, демиелинизиращи, неопластични, възпалителни и др. Представяме 81 годишен болен с остро развил се синдром „едно и половина” и съпътстваща унилатерална лекостепенна птоза като дебютен симптом на миастения гравис. В случая миастенната симптоматика имитира структурна понтинна лезия.
- 30 April 2026
- Published by Bulgarian Society of Neurology in Bulgarian Neurology
- Vol. 27 (1) , 18-21
Open AccessСиндромът „Едно и половина” на Fisher (Fisher’s “One and a half syndrome”) при миастения гравис - описание на случай
Синдромът „едно и половина” на Fisher е рядка очедвигателна лезия, характеризираща се с хоризонтална погледна пареза в едната посока в съчетание с интернуклеарна офталмопареза в другата посока. Дължи се на унилатерална понтинна лезия, засягаща ипсилатералната парамедианна понтинна ретикуларна формация и/или ипсилатералното ядро на n. abducens и интернуклеарните фибри на ипсилатералния медиален лонгитудинален фасцикул. Описан е при стволови лезии с различна етиология – съдови, демиелинизиращи, неопластични, възпалителни и др. Представяме 81 годишен болен с остро развил се синдром „едно и половина” и съпътстваща унилатерална лекостепенна птоза като дебютен симптом на миастения гравис. В случая миастенната симптоматика имитира структурна понтинна лезия.
- Open Access
- 5 September 2018
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 13 (1) , 1-11
Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease
Myotonic Dystrophy is the most common form of muscular dystrophy in adults, affecting an estimated 10 per 100,000 people. It is a multisystemic disorder affecting multiple generations with increasing severity. There are currently no licenced therapies to reverse, slow down or cure its symptoms. In 2009 TREAT-NMD (a global alliance with the mission of improving trial readiness for neuromuscular diseases) and the Marigold Foundation held a workshop of key opinion leaders to agree a minimal dataset for patient registries in myotonic dystrophy. Eight years after this workshop, we surveyed 22 registries collecting information on myotonic dystrophy patients to assess the proliferation and utility the dataset agreed in 2009. These registries represent over 10,000 myotonic dystrophy patients worldwide (Europe, North America, Asia and Oceania). The registries use a variety of data collection methods (e.g. online patient surveys or clinician led) and have a variety of budgets (from being run by volunteers to annual budgets over €200,000). All registries collect at least some of the originally agreed data items, and a number of additional items have been suggested in particular items on cognitive impact. The community should consider how to maximise this collective resource in future therapeutic programmes.
- 5 September 2018
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 13 (1) , 1-11
Open AccessEight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease
Myotonic Dystrophy is the most common form of muscular dystrophy in adults, affecting an estimated 10 per 100,000 people. It is a multisystemic disorder affecting multiple generations with increasing severity. There are currently no licenced therapies to reverse, slow down or cure its symptoms. In 2009 TREAT-NMD (a global alliance with the mission of improving trial readiness for neuromuscular diseases) and the Marigold Foundation held a workshop of key opinion leaders to agree a minimal dataset for patient registries in myotonic dystrophy. Eight years after this workshop, we surveyed 22 registries collecting information on myotonic dystrophy patients to assess the proliferation and utility the dataset agreed in 2009. These registries represent over 10,000 myotonic dystrophy patients worldwide (Europe, North America, Asia and Oceania). The registries use a variety of data collection methods (e.g. online patient surveys or clinician led) and have a variety of budgets (from being run by volunteers to annual budgets over €200,000). All registries collect at least some of the originally agreed data items, and a number of additional items have been suggested in particular items on cognitive impact. The community should consider how to maximise this collective resource in future therapeutic programmes.
- 1 August 2018
- Published by Elsevier in Neuromuscular Disorders
- Vol. 28 (8) , 625-632
Limb girdle muscular dystrophy 2G in a religious minority of Bulgarian Muslims homozygous for the c.75G>A, p.Trp25X mutation
- 1 August 2018
- Published by Elsevier in Neuromuscular Disorders
- Vol. 28 (8) , 625-632
Limb girdle muscular dystrophy 2G in a religious minority of Bulgarian Muslims homozygous for the c.75G>A, p.Trp25X mutation